Refractory Peripheral T-Cell Lymphoma

Also known as: Peripheral T-Cell Lymphoma Refractory

DrugDrug NameDrug Description
DB05015BelinostatA histone deacetylase (HDAC) inhibitor used for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
DB06813PralatrexateAn antineoplastic agent used for the treatment of relapsed or refractory peripheral T-cell lymphoma.